3.0.0 4106 2022-11-01T13:50:16Z 2022-11-01T13:50:16Z House HR 2019-07-30 116 [Congressional Record Volume 165, Number 129 (Tuesday, July 30, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. DeLAURO:H.R. 4106.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clauses 3 and 18 of the United StatesConstitution[Page H7482]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2019-07-31T17:14:55Z Referred to 2019-07-30T15:32:45Z 116 2452 HR 2019-05-31 Referred to the Subcommittee on Courts, Intellectual Property, and the Internet. Related bill CRS 116 3180 S 2020-01-09 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Identical bill CRS 2019-07-31 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2019-07-30 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-07-30 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-07-30 Introduced in House IntroReferral 1000 9 Library of Congress D000216 Rep. DeLauro, Rosa L. [D-CT-3] ROSA DELAURO D CT 3 N K000389 Rep. Khanna, Ro [D-CA-17] Ro Khanna D CA 17 2019-07-30 True G000551 Rep. Grijalva, Raúl M. [D-AZ-3] Raúl Grijalva D AZ M. 3 2019-07-30 True P000614 Rep. Pappas, Chris [D-NH-1] Chris Pappas D NH 1 2019-08-02 False Health Drug safety, medical device, and laboratory regulation Marketing and advertising Prescription drugs Health

00 2019-07-30 Introduced in House 2021-09-03T18:28:05Z Responsibility in Drug Advertising Act of 2019

This bill prohibits direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects.]]>

Display Title Official Title as Introduced Introduced in House IH Short Title(s) as Introduced Introduced in House IH Introduced in House 2019-07-30T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr4106ih/xml/BILLS-116hr4106ih.xml 2019-07-31 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.